id	sid	tid	token	lemma	pos
dpc-761	1	1	untitled	untitled	ADJ
dpc-761	1	2	observation	observation	NOUN
dpc-761	1	3	|	|	ADV
dpc-761	1	4	dermatol	dermatol	NOUN
dpc-761	1	5	pract	pract	PROPN
dpc-761	1	6	concept	concept	NOUN
dpc-761	1	7	2015;5(2):14	2015;5(2):14	NUM
dpc-761	1	8	79	79	NUM
dpc-761	1	9	dermatology	dermatology	NOUN
dpc-761	1	10	practical	practical	ADJ
dpc-761	1	11	&	&	CCONJ
dpc-761	1	12	conceptual	conceptual	ADJ
dpc-761	1	13	www.derm101.com	www.derm101.com	NUM
dpc-761	1	14	introduction	introduction	NOUN
dpc-761	1	15	capecitabine	capecitabine	NOUN
dpc-761	1	16	(	(	PUNCT
dpc-761	1	17	xeloda	xeloda	PROPN
dpc-761	1	18	®	®	PROPN
dpc-761	1	19	)	)	PUNCT
dpc-761	1	20	is	be	AUX
dpc-761	1	21	an	an	DET
dpc-761	1	22	orally	orally	ADV
dpc-761	1	23	administered	administer	VERB
dpc-761	1	24	antineoplastic	antineoplastic	ADJ
dpc-761	1	25	pro	pro	ADJ
dpc-761	1	26	-	-	ADJ
dpc-761	1	27	drug	drug	ADJ
dpc-761	1	28	,	,	PUNCT
dpc-761	1	29	which	which	PRON
dpc-761	1	30	in	in	ADP
dpc-761	1	31	tumour	tumour	ADJ
dpc-761	1	32	tissue	tissue	NOUN
dpc-761	1	33	is	be	AUX
dpc-761	1	34	preferentially	preferentially	ADV
dpc-761	1	35	converted	convert	VERB
dpc-761	1	36	to	to	ADP
dpc-761	1	37	5	5	NUM
dpc-761	1	38	-	-	PUNCT
dpc-761	1	39	fluorouracil	fluorouracil	NOUN
dpc-761	1	40	(	(	PUNCT
dpc-761	1	41	5	5	NUM
dpc-761	1	42	-	-	PUNCT
dpc-761	1	43	fu	fu	NOUN
dpc-761	1	44	)	)	PUNCT
dpc-761	1	45	by	by	ADP
dpc-761	1	46	thymidine	thymidine	ADJ
dpc-761	1	47	phosphorylase	phosphorylase	NOUN
dpc-761	1	48	(	(	PUNCT
dpc-761	1	49	tp	tp	NOUN
dpc-761	1	50	)	)	PUNCT
dpc-761	2	1	[	[	X
dpc-761	2	2	1	1	NUM
dpc-761	2	3	]	]	PUNCT
dpc-761	2	4	.	.	PUNCT
dpc-761	3	1	it	it	PRON
dpc-761	3	2	is	be	AUX
dpc-761	3	3	used	use	VERB
dpc-761	3	4	as	as	ADP
dpc-761	3	5	adjuvant	adjuvant	ADJ
dpc-761	3	6	chemotherapy	chemotherapy	NOUN
dpc-761	3	7	for	for	ADP
dpc-761	3	8	metastatic	metastatic	ADJ
dpc-761	3	9	breast	breast	NOUN
dpc-761	3	10	and	and	CCONJ
dpc-761	3	11	colon	colon	NOUN
dpc-761	3	12	cancer	cancer	NOUN
dpc-761	3	13	[	[	X
dpc-761	3	14	2	2	NUM
dpc-761	3	15	]	]	PUNCT
dpc-761	3	16	.	.	PUNCT
dpc-761	4	1	common	common	ADJ
dpc-761	4	2	dose	dose	NOUN
dpc-761	4	3	-	-	PUNCT
dpc-761	4	4	limiting	limit	VERB
dpc-761	4	5	sideeffects	sideeffect	NOUN
dpc-761	4	6	of	of	ADP
dpc-761	4	7	capecitabine	capecitabine	NOUN
dpc-761	4	8	include	include	VERB
dpc-761	4	9	hyperbilirubinemia	hyperbilirubinemia	NOUN
dpc-761	4	10	,	,	PUNCT
dpc-761	4	11	nausea	nausea	NOUN
dpc-761	4	12	,	,	PUNCT
dpc-761	4	13	vomiting	vomiting	NOUN
dpc-761	4	14	,	,	PUNCT
dpc-761	4	15	diarrhoea	diarrhoea	NOUN
dpc-761	4	16	,	,	PUNCT
dpc-761	4	17	bone	bone	NOUN
dpc-761	4	18	marrow	marrow	NOUN
dpc-761	4	19	suppression	suppression	NOUN
dpc-761	4	20	and	and	CCONJ
dpc-761	4	21	hand	hand	NOUN
dpc-761	4	22	and	and	CCONJ
dpc-761	4	23	foot	foot	NOUN
dpc-761	4	24	syndrome	syndrome	NOUN
dpc-761	4	25	(	(	PUNCT
dpc-761	4	26	hfs	hfs	PROPN
dpc-761	4	27	)	)	PUNCT
dpc-761	5	1	[	[	X
dpc-761	5	2	1	1	NUM
dpc-761	5	3	-	-	SYM
dpc-761	5	4	3	3	NUM
dpc-761	5	5	]	]	PUNCT
dpc-761	5	6	.	.	PUNCT
dpc-761	6	1	capecitabine	capecitabine	NOUN
dpc-761	6	2	-	-	PUNCT
dpc-761	6	3	induced	induce	VERB
dpc-761	6	4	skin	skin	NOUN
dpc-761	6	5	pigmentation	pigmentation	NOUN
dpc-761	6	6	may	may	AUX
dpc-761	6	7	occur	occur	VERB
dpc-761	6	8	in	in	ADP
dpc-761	6	9	the	the	DET
dpc-761	6	10	context	context	NOUN
dpc-761	6	11	of	of	ADP
dpc-761	6	12	skin	skin	NOUN
dpc-761	6	13	manifestations	manifestation	NOUN
dpc-761	6	14	of	of	ADP
dpc-761	6	15	hfs	hfs	NOUN
dpc-761	6	16	[	[	X
dpc-761	6	17	4	4	NUM
dpc-761	6	18	-	-	SYM
dpc-761	6	19	9	9	NUM
dpc-761	6	20	]	]	PUNCT
dpc-761	6	21	.	.	PUNCT
dpc-761	7	1	case	case	NOUN
dpc-761	7	2	report	report	VERB
dpc-761	7	3	a	a	DET
dpc-761	7	4	37	37	NUM
dpc-761	7	5	-	-	PUNCT
dpc-761	7	6	year	year	NOUN
dpc-761	7	7	-	-	PUNCT
dpc-761	7	8	old	old	ADJ
dpc-761	7	9	woman	woman	NOUN
dpc-761	7	10	(	(	PUNCT
dpc-761	7	11	phototype	phototype	PROPN
dpc-761	7	12	ii	ii	PROPN
dpc-761	7	13	)	)	PUNCT
dpc-761	7	14	presented	present	VERB
dpc-761	7	15	with	with	ADP
dpc-761	7	16	irregular	irregular	ADJ
dpc-761	7	17	pigmented	pigmented	ADJ
dpc-761	7	18	macules	macule	NOUN
dpc-761	7	19	in	in	ADP
dpc-761	7	20	the	the	DET
dpc-761	7	21	plantar	plantar	NOUN
dpc-761	7	22	regions	region	NOUN
dpc-761	7	23	.	.	PUNCT
dpc-761	8	1	the	the	DET
dpc-761	8	2	lesions	lesion	NOUN
dpc-761	8	3	were	be	AUX
dpc-761	8	4	roundish	roundish	ADJ
dpc-761	8	5	in	in	ADP
dpc-761	8	6	shape	shape	NOUN
dpc-761	8	7	,	,	PUNCT
dpc-761	8	8	0.2	0.2	NUM
dpc-761	8	9	-	-	SYM
dpc-761	8	10	0.5	0.5	NUM
dpc-761	8	11	cm	cm	NOUN
dpc-761	8	12	in	in	ADP
dpc-761	8	13	diameter	diameter	NOUN
dpc-761	8	14	and	and	CCONJ
dpc-761	8	15	light	light	NOUN
dpc-761	8	16	to	to	ADP
dpc-761	8	17	dark	dark	ADJ
dpc-761	8	18	brown	brown	NOUN
dpc-761	8	19	in	in	ADP
dpc-761	8	20	colour	colour	NOUN
dpc-761	8	21	with	with	ADP
dpc-761	8	22	poorly	poorly	ADV
dpc-761	8	23	defined	define	VERB
dpc-761	8	24	margins	margin	NOUN
dpc-761	8	25	(	(	PUNCT
dpc-761	8	26	figure	figure	NOUN
dpc-761	8	27	1	1	NUM
dpc-761	8	28	)	)	PUNCT
dpc-761	8	29	.	.	PUNCT
dpc-761	9	1	they	they	PRON
dpc-761	9	2	appeared	appear	VERB
dpc-761	9	3	nearly	nearly	ADV
dpc-761	9	4	two	two	NUM
dpc-761	9	5	months	month	NOUN
dpc-761	9	6	before	before	ADP
dpc-761	9	7	our	our	PRON
dpc-761	9	8	observation	observation	NOUN
dpc-761	9	9	.	.	PUNCT
dpc-761	10	1	no	no	DET
dpc-761	10	2	other	other	ADJ
dpc-761	10	3	body	body	NOUN
dpc-761	10	4	sites	site	NOUN
dpc-761	10	5	were	be	AUX
dpc-761	10	6	involved	involve	VERB
dpc-761	10	7	.	.	PUNCT
dpc-761	11	1	dermoscopic	dermoscopic	NOUN
dpc-761	11	2	examination	examination	NOUN
dpc-761	11	3	showed	show	VERB
dpc-761	11	4	parallel	parallel	ADJ
dpc-761	11	5	ridge	ridge	NOUN
dpc-761	11	6	pattern	pattern	NOUN
dpc-761	11	7	with	with	ADP
dpc-761	11	8	preservation	preservation	NOUN
dpc-761	11	9	of	of	ADP
dpc-761	11	10	eccrine	eccrine	ADJ
dpc-761	11	11	gland	gland	NOUN
dpc-761	11	12	apertures	aperture	NOUN
dpc-761	11	13	(	(	PUNCT
dpc-761	11	14	figure	figure	NOUN
dpc-761	11	15	2	2	NUM
dpc-761	11	16	)	)	PUNCT
dpc-761	11	17	.	.	PUNCT
dpc-761	12	1	clinical	clinical	ADJ
dpc-761	12	2	history	history	NOUN
dpc-761	12	3	revealed	reveal	VERB
dpc-761	12	4	that	that	SCONJ
dpc-761	12	5	the	the	DET
dpc-761	12	6	patient	patient	NOUN
dpc-761	12	7	had	have	AUX
dpc-761	12	8	taken	take	VERB
dpc-761	12	9	capecitabine	capecitabine	NOUN
dpc-761	12	10	(	(	PUNCT
dpc-761	12	11	xeloda	xeloda	PROPN
dpc-761	12	12	®	®	PROPN
dpc-761	12	13	)	)	PUNCT
dpc-761	12	14	in	in	ADP
dpc-761	12	15	the	the	DET
dpc-761	12	16	last	last	ADJ
dpc-761	12	17	two	two	NUM
dpc-761	12	18	months	month	NOUN
dpc-761	12	19	as	as	ADP
dpc-761	12	20	adjuvant	adjuvant	ADJ
dpc-761	12	21	chemotherapy	chemotherapy	NOUN
dpc-761	12	22	for	for	ADP
dpc-761	12	23	recurrent	recurrent	ADJ
dpc-761	12	24	breast	breast	NOUN
dpc-761	12	25	cancer	cancer	NOUN
dpc-761	12	26	.	.	PUNCT
dpc-761	13	1	benign	benign	ADJ
dpc-761	13	2	dermoscopic	dermoscopic	PROPN
dpc-761	13	3	parallel	parallel	PROPN
dpc-761	13	4	ridge	ridge	NOUN
dpc-761	13	5	pattern	pattern	NOUN
dpc-761	13	6	in	in	ADP
dpc-761	13	7	plantar	plantar	NOUN
dpc-761	13	8	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	13	9	due	due	ADP
dpc-761	13	10	to	to	PART
dpc-761	13	11	capecitabine	capecitabine	VERB
dpc-761	13	12	linda	linda	PROPN
dpc-761	13	13	tognetti1	tognetti1	PROPN
dpc-761	13	14	,	,	PUNCT
dpc-761	13	15	michele	michele	PROPN
dpc-761	13	16	fimiani1	fimiani1	PROPN
dpc-761	13	17	,	,	PUNCT
dpc-761	13	18	pietro	pietro	NOUN
dpc-761	13	19	rubegni1	rubegni1	PROPN
dpc-761	13	20	1	1	NUM
dpc-761	13	21	department	department	NOUN
dpc-761	13	22	of	of	ADP
dpc-761	13	23	clinical	clinical	ADJ
dpc-761	13	24	medicine	medicine	NOUN
dpc-761	13	25	and	and	CCONJ
dpc-761	13	26	immunological	immunological	ADJ
dpc-761	13	27	sciences	science	NOUN
dpc-761	13	28	,	,	PUNCT
dpc-761	13	29	dermatology	dermatology	NOUN
dpc-761	13	30	section	section	NOUN
dpc-761	13	31	,	,	PUNCT
dpc-761	13	32	university	university	PROPN
dpc-761	13	33	of	of	ADP
dpc-761	13	34	siena	siena	PROPN
dpc-761	13	35	,	,	PUNCT
dpc-761	13	36	siena	siena	PROPN
dpc-761	13	37	,	,	PUNCT
dpc-761	13	38	italy	italy	PROPN
dpc-761	13	39	key	key	PROPN
dpc-761	13	40	words	word	NOUN
dpc-761	13	41	:	:	PUNCT
dpc-761	13	42	dermoscopy	dermoscopy	NOUN
dpc-761	13	43	,	,	PUNCT
dpc-761	13	44	capecitabine	capecitabine	NOUN
dpc-761	13	45	,	,	PUNCT
dpc-761	13	46	plantar	plantar	NOUN
dpc-761	13	47	,	,	PUNCT
dpc-761	13	48	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	13	49	citation	citation	NOUN
dpc-761	13	50	:	:	PUNCT
dpc-761	13	51	tognetti	tognetti	PROPN
dpc-761	13	52	l	l	PROPN
dpc-761	13	53	,	,	PUNCT
dpc-761	13	54	fimiani	fimiani	PROPN
dpc-761	13	55	m	m	PROPN
dpc-761	13	56	,	,	PUNCT
dpc-761	13	57	rubegni	rubegni	NOUN
dpc-761	13	58	p.	p.	NOUN
dpc-761	13	59	benign	benign	PROPN
dpc-761	13	60	dermoscopic	dermoscopic	PROPN
dpc-761	13	61	parallel	parallel	PROPN
dpc-761	13	62	ridge	ridge	NOUN
dpc-761	13	63	pattern	pattern	NOUN
dpc-761	13	64	in	in	ADP
dpc-761	13	65	plantar	plantar	NOUN
dpc-761	13	66	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	13	67	due	due	ADP
dpc-761	13	68	to	to	PART
dpc-761	13	69	capecitabine	capecitabine	VERB
dpc-761	13	70	.	.	PUNCT
dpc-761	14	1	dermatol	dermatol	NOUN
dpc-761	14	2	pract	pract	PROPN
dpc-761	14	3	concept	concept	NOUN
dpc-761	15	1	2015;5(2):14	2015;5(2):14	NUM
dpc-761	15	2	.	.	PUNCT
dpc-761	15	3	doi	doi	NOUN
dpc-761	15	4	:	:	PUNCT
dpc-761	15	5	10.5826	10.5826	NUM
dpc-761	15	6	/	/	SYM
dpc-761	15	7	dpc.0502a14	dpc.0502a14	PROPN
dpc-761	15	8	received	receive	VERB
dpc-761	15	9	:	:	PUNCT
dpc-761	15	10	october	october	PROPN
dpc-761	15	11	25	25	NUM
dpc-761	15	12	,	,	PUNCT
dpc-761	15	13	2014	2014	NUM
dpc-761	15	14	;	;	PUNCT
dpc-761	15	15	accepted	accept	VERB
dpc-761	15	16	:	:	PUNCT
dpc-761	15	17	january	january	PROPN
dpc-761	15	18	9	9	NUM
dpc-761	15	19	,	,	PUNCT
dpc-761	15	20	2015	2015	NUM
dpc-761	15	21	;	;	PUNCT
dpc-761	15	22	published	publish	VERB
dpc-761	15	23	:	:	PUNCT
dpc-761	15	24	april	april	PROPN
dpc-761	15	25	30	30	NUM
dpc-761	15	26	,	,	PUNCT
dpc-761	15	27	2015	2015	NUM
dpc-761	15	28	copyright	copyright	NOUN
dpc-761	15	29	:	:	PUNCT
dpc-761	16	1	©	©	PROPN
dpc-761	16	2	2015	2015	NUM
dpc-761	16	3	tognetti	tognetti	NOUN
dpc-761	16	4	et	et	PROPN
dpc-761	16	5	al	al	PROPN
dpc-761	16	6	.	.	PUNCT
dpc-761	17	1	this	this	PRON
dpc-761	17	2	is	be	AUX
dpc-761	17	3	an	an	DET
dpc-761	17	4	open	open	ADJ
dpc-761	17	5	-	-	PUNCT
dpc-761	17	6	access	access	NOUN
dpc-761	17	7	article	article	NOUN
dpc-761	17	8	distributed	distribute	VERB
dpc-761	17	9	under	under	ADP
dpc-761	17	10	the	the	DET
dpc-761	17	11	terms	term	NOUN
dpc-761	17	12	of	of	ADP
dpc-761	17	13	the	the	DET
dpc-761	17	14	creative	creative	ADJ
dpc-761	17	15	commons	common	NOUN
dpc-761	17	16	attribution	attribution	NOUN
dpc-761	17	17	license	license	NOUN
dpc-761	17	18	,	,	PUNCT
dpc-761	17	19	which	which	PRON
dpc-761	17	20	permits	permit	VERB
dpc-761	17	21	unrestricted	unrestricted	ADJ
dpc-761	17	22	use	use	NOUN
dpc-761	17	23	,	,	PUNCT
dpc-761	17	24	distribution	distribution	NOUN
dpc-761	17	25	,	,	PUNCT
dpc-761	17	26	and	and	CCONJ
dpc-761	17	27	reproduction	reproduction	NOUN
dpc-761	17	28	in	in	ADP
dpc-761	17	29	any	any	DET
dpc-761	17	30	medium	medium	NOUN
dpc-761	17	31	,	,	PUNCT
dpc-761	17	32	provided	provide	VERB
dpc-761	17	33	the	the	DET
dpc-761	17	34	original	original	ADJ
dpc-761	17	35	author	author	NOUN
dpc-761	17	36	and	and	CCONJ
dpc-761	17	37	source	source	NOUN
dpc-761	17	38	are	be	AUX
dpc-761	17	39	credited	credit	VERB
dpc-761	17	40	.	.	PUNCT
dpc-761	18	1	funding	funding	NOUN
dpc-761	18	2	:	:	PUNCT
dpc-761	18	3	none	none	NOUN
dpc-761	18	4	.	.	PUNCT
dpc-761	19	1	competing	compete	VERB
dpc-761	19	2	interests	interest	NOUN
dpc-761	19	3	:	:	PUNCT
dpc-761	19	4	the	the	DET
dpc-761	19	5	authors	author	NOUN
dpc-761	19	6	have	have	VERB
dpc-761	19	7	no	no	DET
dpc-761	19	8	conflicts	conflict	NOUN
dpc-761	19	9	of	of	ADP
dpc-761	19	10	interest	interest	NOUN
dpc-761	19	11	to	to	PART
dpc-761	19	12	disclose	disclose	VERB
dpc-761	19	13	.	.	PUNCT
dpc-761	20	1	all	all	DET
dpc-761	20	2	authors	author	NOUN
dpc-761	20	3	have	have	AUX
dpc-761	20	4	contributed	contribute	VERB
dpc-761	20	5	significantly	significantly	ADV
dpc-761	20	6	to	to	ADP
dpc-761	20	7	this	this	DET
dpc-761	20	8	publication	publication	NOUN
dpc-761	20	9	.	.	PUNCT
dpc-761	21	1	corresponding	correspond	VERB
dpc-761	21	2	author	author	NOUN
dpc-761	21	3	:	:	PUNCT
dpc-761	21	4	linda	linda	PROPN
dpc-761	21	5	tognetti	tognetti	PROPN
dpc-761	21	6	,	,	PUNCT
dpc-761	21	7	md	md	PROPN
dpc-761	21	8	,	,	PUNCT
dpc-761	21	9	dermatology	dermatology	NOUN
dpc-761	21	10	unit	unit	NOUN
dpc-761	21	11	,	,	PUNCT
dpc-761	21	12	le	le	X
dpc-761	21	13	scotte	scotte	ADJ
dpc-761	21	14	hospital	hospital	NOUN
dpc-761	21	15	,	,	PUNCT
dpc-761	21	16	aous	aous	ADJ
dpc-761	21	17	,	,	PUNCT
dpc-761	21	18	v.	v.	ADP
dpc-761	21	19	le	le	AUX
dpc-761	21	20	bracci	bracci	PROPN
dpc-761	21	21	14	14	NUM
dpc-761	21	22	,	,	PUNCT
dpc-761	21	23	53100	53100	NUM
dpc-761	21	24	siena	siena	PROPN
dpc-761	21	25	,	,	PUNCT
dpc-761	21	26	italy	italy	PROPN
dpc-761	21	27	.	.	PUNCT
dpc-761	22	1	tel	tel	PROPN
dpc-761	22	2	.	.	PUNCT
dpc-761	23	1	+39	+39	PROPN
dpc-761	23	2	0577	0577	NUM
dpc-761	23	3	5855893	5855893	NUM
dpc-761	23	4	;	;	PUNCT
dpc-761	23	5	fax	fax	NOUN
dpc-761	23	6	.	.	PROPN
dpc-761	24	1	+39	+39	PROPN
dpc-761	24	2	0577	0577	NUM
dpc-761	24	3	585327	585327	NUM
dpc-761	24	4	.	.	PUNCT
dpc-761	25	1	e	e	X
dpc-761	25	2	-	-	NOUN
dpc-761	25	3	mail	mail	NOUN
dpc-761	25	4	:	:	PUNCT
dpc-761	25	5	linda.tognetti@gmail.com	linda.tognetti@gmail.com	X
dpc-761	25	6	we	we	PRON
dpc-761	25	7	report	report	VERB
dpc-761	25	8	the	the	DET
dpc-761	25	9	case	case	NOUN
dpc-761	25	10	of	of	ADP
dpc-761	25	11	a	a	DET
dpc-761	25	12	37	37	NUM
dpc-761	25	13	-	-	PUNCT
dpc-761	25	14	year	year	NOUN
dpc-761	25	15	-	-	PUNCT
dpc-761	25	16	old	old	ADJ
dpc-761	25	17	woman	woman	NOUN
dpc-761	25	18	(	(	PUNCT
dpc-761	25	19	phototype	phototype	PROPN
dpc-761	25	20	ii	ii	PROPN
dpc-761	25	21	)	)	PUNCT
dpc-761	25	22	who	who	PRON
dpc-761	25	23	presented	present	VERB
dpc-761	25	24	at	at	ADP
dpc-761	25	25	our	our	PRON
dpc-761	25	26	outpatient	outpatient	NOUN
dpc-761	25	27	clinic	clinic	NOUN
dpc-761	25	28	with	with	ADP
dpc-761	25	29	a	a	DET
dpc-761	25	30	two	two	NUM
dpc-761	25	31	-	-	PUNCT
dpc-761	25	32	month	month	NOUN
dpc-761	25	33	history	history	NOUN
dpc-761	25	34	of	of	ADP
dpc-761	25	35	hyperpigmented	hyperpigmente	VERB
dpc-761	25	36	plantar	plantar	NOUN
dpc-761	25	37	macules	macule	NOUN
dpc-761	25	38	.	.	PUNCT
dpc-761	26	1	medical	medical	ADJ
dpc-761	26	2	history	history	NOUN
dpc-761	26	3	revealed	reveal	VERB
dpc-761	26	4	that	that	SCONJ
dpc-761	26	5	the	the	DET
dpc-761	26	6	patient	patient	NOUN
dpc-761	26	7	had	have	AUX
dpc-761	26	8	taken	take	VERB
dpc-761	26	9	capecitabine	capecitabine	NOUN
dpc-761	26	10	in	in	ADP
dpc-761	26	11	the	the	DET
dpc-761	26	12	past	past	ADJ
dpc-761	26	13	three	three	NUM
dpc-761	26	14	months	month	NOUN
dpc-761	26	15	as	as	ADP
dpc-761	26	16	adjuvant	adjuvant	ADJ
dpc-761	26	17	chemotherapy	chemotherapy	NOUN
dpc-761	26	18	for	for	ADP
dpc-761	26	19	recurrent	recurrent	ADJ
dpc-761	26	20	breast	breast	NOUN
dpc-761	26	21	cancer	cancer	NOUN
dpc-761	26	22	.	.	PUNCT
dpc-761	27	1	dermoscopic	dermoscopic	ADJ
dpc-761	27	2	examination	examination	NOUN
dpc-761	27	3	of	of	ADP
dpc-761	27	4	the	the	DET
dpc-761	27	5	plantar	plantar	NOUN
dpc-761	27	6	macules	macule	NOUN
dpc-761	27	7	showed	show	VERB
dpc-761	27	8	parallel	parallel	ADJ
dpc-761	27	9	ridge	ridge	NOUN
dpc-761	27	10	pattern	pattern	NOUN
dpc-761	27	11	with	with	ADP
dpc-761	27	12	pigmentation	pigmentation	NOUN
dpc-761	27	13	in	in	ADP
dpc-761	27	14	the	the	DET
dpc-761	27	15	furrows	furrow	NOUN
dpc-761	27	16	without	without	ADP
dpc-761	27	17	obliteration	obliteration	NOUN
dpc-761	27	18	of	of	ADP
dpc-761	27	19	eccrine	eccrine	ADJ
dpc-761	27	20	gland	gland	NOUN
dpc-761	27	21	apertures	aperture	NOUN
dpc-761	27	22	.	.	PUNCT
dpc-761	28	1	besides	besides	ADV
dpc-761	28	2	in	in	ADP
dpc-761	28	3	acral	acral	ADJ
dpc-761	28	4	melanoma	melanoma	NOUN
dpc-761	28	5	,	,	PUNCT
dpc-761	28	6	parallel	parallel	ADJ
dpc-761	28	7	ridge	ridge	NOUN
dpc-761	28	8	pattern	pattern	NOUN
dpc-761	28	9	can	can	AUX
dpc-761	28	10	also	also	ADV
dpc-761	28	11	be	be	AUX
dpc-761	28	12	observed	observe	VERB
dpc-761	28	13	in	in	ADP
dpc-761	28	14	benign	benign	ADJ
dpc-761	28	15	plantar	plantar	NOUN
dpc-761	28	16	lesions	lesion	NOUN
dpc-761	28	17	,	,	PUNCT
dpc-761	28	18	such	such	ADJ
dpc-761	28	19	as	as	ADP
dpc-761	28	20	congenital	congenital	ADJ
dpc-761	28	21	or	or	CCONJ
dpc-761	28	22	acquired	acquire	VERB
dpc-761	28	23	acral	acral	ADJ
dpc-761	28	24	nevi	nevi	PROPN
dpc-761	28	25	,	,	PUNCT
dpc-761	28	26	subcorneal	subcorneal	ADJ
dpc-761	28	27	hemorrhage	hemorrhage	NOUN
dpc-761	28	28	,	,	PUNCT
dpc-761	28	29	dye	dye	NOUN
dpc-761	28	30	-	-	PUNCT
dpc-761	28	31	related	relate	VERB
dpc-761	28	32	pigmentation	pigmentation	NOUN
dpc-761	28	33	and	and	CCONJ
dpc-761	28	34	drug	drug	NOUN
dpc-761	28	35	-	-	PUNCT
dpc-761	28	36	induced	induce	VERB
dpc-761	28	37	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	28	38	,	,	PUNCT
dpc-761	28	39	especially	especially	ADV
dpc-761	28	40	in	in	ADP
dpc-761	28	41	patients	patient	NOUN
dpc-761	28	42	with	with	ADP
dpc-761	28	43	phototypes	phototype	NOUN
dpc-761	28	44	iii	iii	NOUN
dpc-761	28	45	-	-	PUNCT
dpc-761	28	46	vi	vi	NOUN
dpc-761	28	47	.	.	PUNCT
dpc-761	29	1	the	the	DET
dpc-761	29	2	few	few	ADJ
dpc-761	29	3	reported	report	VERB
dpc-761	29	4	cases	case	NOUN
dpc-761	29	5	of	of	ADP
dpc-761	29	6	capecitabine	capecitabine	NOUN
dpc-761	29	7	-	-	PUNCT
dpc-761	29	8	induced	induce	VERB
dpc-761	29	9	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	29	10	have	have	AUX
dpc-761	29	11	been	be	AUX
dpc-761	29	12	associated	associate	VERB
dpc-761	29	13	with	with	ADP
dpc-761	29	14	hand	hand	NOUN
dpc-761	29	15	and	and	CCONJ
dpc-761	29	16	foot	foot	NOUN
dpc-761	29	17	syndrome	syndrome	NOUN
dpc-761	29	18	in	in	ADP
dpc-761	29	19	patients	patient	NOUN
dpc-761	29	20	with	with	ADP
dpc-761	29	21	phototypes	phototype	NOUN
dpc-761	29	22	iv	iv	NOUN
dpc-761	29	23	-	-	PUNCT
dpc-761	29	24	v	v	NOUN
dpc-761	29	25	and	and	CCONJ
dpc-761	29	26	palmar	palmar	VERB
dpc-761	29	27	as	as	ADV
dpc-761	29	28	well	well	ADV
dpc-761	29	29	as	as	ADP
dpc-761	29	30	plantar	plantar	NOUN
dpc-761	29	31	involvement	involvement	NOUN
dpc-761	29	32	.	.	PUNCT
dpc-761	30	1	abstract	abstract	ADJ
dpc-761	30	2	80	80	NUM
dpc-761	30	3	observation	observation	NOUN
dpc-761	31	1	|	|	ADV
dpc-761	32	1	dermatol	dermatol	NOUN
dpc-761	32	2	pract	pract	PROPN
dpc-761	32	3	concept	concept	VERB
dpc-761	32	4	2015;5(2):14	2015;5(2):14	NUM
dpc-761	32	5	discussion	discussion	NOUN
dpc-761	32	6	to	to	ADP
dpc-761	32	7	our	our	PRON
dpc-761	32	8	knowledge	knowledge	NOUN
dpc-761	32	9	,	,	PUNCT
dpc-761	32	10	very	very	ADV
dpc-761	32	11	few	few	ADJ
dpc-761	32	12	cases	case	NOUN
dpc-761	32	13	of	of	ADP
dpc-761	32	14	capecitabine	capecitabine	NOUN
dpc-761	32	15	-	-	PUNCT
dpc-761	32	16	induced	induce	VERB
dpc-761	32	17	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	32	18	have	have	AUX
dpc-761	32	19	been	be	AUX
dpc-761	32	20	reported	report	VERB
dpc-761	32	21	[	[	PUNCT
dpc-761	32	22	6	6	NUM
dpc-761	32	23	-	-	SYM
dpc-761	32	24	13	13	NUM
dpc-761	32	25	]	]	PUNCT
dpc-761	32	26	,	,	PUNCT
dpc-761	32	27	and	and	CCONJ
dpc-761	32	28	have	have	AUX
dpc-761	32	29	mainly	mainly	ADV
dpc-761	32	30	been	be	AUX
dpc-761	32	31	in	in	ADP
dpc-761	32	32	patients	patient	NOUN
dpc-761	32	33	with	with	ADP
dpc-761	32	34	phototype	phototype	NOUN
dpc-761	32	35	iv	iv	ADP
dpc-761	32	36	or	or	CCONJ
dpc-761	32	37	v	v	ADP
dpc-761	32	38	(	(	PUNCT
dpc-761	32	39	indians	indians	PROPN
dpc-761	32	40	[	[	X
dpc-761	32	41	8,9	8,9	NUM
dpc-761	32	42	]	]	PUNCT
dpc-761	32	43	,	,	PUNCT
dpc-761	32	44	africans	africans	PROPN
dpc-761	32	45	[	[	X
dpc-761	32	46	5,6,10	5,6,10	NUM
dpc-761	32	47	]	]	PUNCT
dpc-761	32	48	,	,	PUNCT
dpc-761	32	49	asians	asian	NOUN
dpc-761	32	50	and	and	CCONJ
dpc-761	32	51	aborigines	aborigine	NOUN
dpc-761	32	52	[	[	X
dpc-761	32	53	8	8	NUM
dpc-761	32	54	]	]	NUM
dpc-761	32	55	)	)	PUNCT
dpc-761	32	56	,	,	PUNCT
dpc-761	32	57	with	with	ADP
dpc-761	32	58	only	only	ADV
dpc-761	32	59	one	one	NUM
dpc-761	32	60	case	case	NOUN
dpc-761	32	61	in	in	ADP
dpc-761	32	62	a	a	DET
dpc-761	32	63	patient	patient	NOUN
dpc-761	32	64	with	with	ADP
dpc-761	32	65	phototype	phototype	NOUN
dpc-761	32	66	iii	iii	X
dpc-761	33	1	[	[	X
dpc-761	33	2	7	7	NUM
dpc-761	33	3	]	]	PUNCT
dpc-761	33	4	,	,	PUNCT
dpc-761	33	5	suggesting	suggest	VERB
dpc-761	33	6	a	a	DET
dpc-761	33	7	racial	racial	ADJ
dpc-761	33	8	predisposition	predisposition	NOUN
dpc-761	33	9	[	[	X
dpc-761	33	10	13	13	NUM
dpc-761	33	11	]	]	PUNCT
dpc-761	33	12	.	.	PUNCT
dpc-761	34	1	in	in	ADP
dpc-761	34	2	all	all	DET
dpc-761	34	3	eleven	eleven	NUM
dpc-761	34	4	cases	case	NOUN
dpc-761	34	5	,	,	PUNCT
dpc-761	34	6	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	34	7	involved	involve	VERB
dpc-761	34	8	palmar	palmar	NOUN
dpc-761	34	9	and	and	CCONJ
dpc-761	34	10	plantar	plantar	NOUN
dpc-761	34	11	skin	skin	NOUN
dpc-761	34	12	[	[	X
dpc-761	34	13	7,8,10,11	7,8,10,11	PROPN
dpc-761	34	14	]	]	PUNCT
dpc-761	34	15	;	;	PUNCT
dpc-761	34	16	the	the	DET
dpc-761	34	17	oral	oral	ADJ
dpc-761	34	18	mucosa	mucosa	NOUN
dpc-761	34	19	was	be	AUX
dpc-761	34	20	also	also	ADV
dpc-761	34	21	involved	involve	VERB
dpc-761	34	22	in	in	ADP
dpc-761	34	23	five	five	NUM
dpc-761	34	24	cases	case	NOUN
dpc-761	34	25	(	(	PUNCT
dpc-761	34	26	four	four	NUM
dpc-761	34	27	africans	africans	PROPN
dpc-761	34	28	and	and	CCONJ
dpc-761	34	29	one	one	NUM
dpc-761	34	30	indian	indian	NOUN
dpc-761	34	31	)	)	PUNCT
dpc-761	35	1	[	[	X
dpc-761	35	2	5,6,9	5,6,9	NUM
dpc-761	35	3	]	]	X
dpc-761	35	4	.	.	PUNCT
dpc-761	36	1	in	in	ADP
dpc-761	36	2	all	all	DET
dpc-761	36	3	cases	case	NOUN
dpc-761	36	4	,	,	PUNCT
dpc-761	36	5	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	36	6	preceded	precede	VERB
dpc-761	36	7	hfs6	hfs6	ADJ
dpc-761	37	1	[	[	X
dpc-761	37	2	8	8	NUM
dpc-761	37	3	-	-	SYM
dpc-761	37	4	11	11	NUM
dpc-761	37	5	]	]	PUNCT
dpc-761	37	6	,	,	PUNCT
dpc-761	37	7	or	or	CCONJ
dpc-761	37	8	was	be	AUX
dpc-761	37	9	associated	associate	VERB
dpc-761	37	10	with	with	ADP
dpc-761	37	11	palmo	palmo	NOUN
dpc-761	37	12	-	-	PUNCT
dpc-761	37	13	plantar	plantar	NOUN
dpc-761	37	14	dysesthesia	dysesthesia	NOUN
dpc-761	38	1	[	[	X
dpc-761	38	2	5,7	5,7	NUM
dpc-761	38	3	]	]	PUNCT
dpc-761	38	4	.	.	PUNCT
dpc-761	39	1	indeed	indeed	ADV
dpc-761	39	2	,	,	PUNCT
dpc-761	39	3	many	many	ADJ
dpc-761	39	4	authors	author	NOUN
dpc-761	39	5	regard	regard	VERB
dpc-761	39	6	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	39	7	as	as	ADP
dpc-761	39	8	one	one	NUM
dpc-761	39	9	of	of	ADP
dpc-761	39	10	the	the	DET
dpc-761	39	11	initial	initial	ADJ
dpc-761	39	12	manifestation	manifestation	NOUN
dpc-761	39	13	of	of	ADP
dpc-761	39	14	hfs	hfs	PROPN
dpc-761	39	15	(	(	PUNCT
dpc-761	39	16	grade	grade	NOUN
dpc-761	39	17	1	1	NUM
dpc-761	39	18	hfs	hfs	PROPN
dpc-761	39	19	)	)	PUNCT
dpc-761	40	1	[	[	X
dpc-761	40	2	7	7	NUM
dpc-761	40	3	-	-	SYM
dpc-761	40	4	9	9	NUM
dpc-761	40	5	]	]	PUNCT
dpc-761	40	6	.	.	PUNCT
dpc-761	41	1	by	by	ADP
dpc-761	41	2	contrast	contrast	NOUN
dpc-761	41	3	,	,	PUNCT
dpc-761	41	4	we	we	PRON
dpc-761	41	5	observed	observe	VERB
dpc-761	41	6	capecitabine	capecitabine	NOUN
dpc-761	41	7	-	-	PUNCT
dpc-761	41	8	induced	induce	VERB
dpc-761	41	9	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	41	10	limited	limit	VERB
dpc-761	41	11	to	to	ADP
dpc-761	41	12	the	the	DET
dpc-761	41	13	plantar	plantar	NOUN
dpc-761	41	14	regions	region	NOUN
dpc-761	41	15	in	in	ADP
dpc-761	41	16	a	a	DET
dpc-761	41	17	phototype	phototype	NOUN
dpc-761	41	18	ii	ii	NOUN
dpc-761	41	19	patient	patient	NOUN
dpc-761	41	20	without	without	ADP
dpc-761	41	21	any	any	DET
dpc-761	41	22	history	history	NOUN
dpc-761	41	23	,	,	PUNCT
dpc-761	41	24	sign	sign	NOUN
dpc-761	41	25	or	or	CCONJ
dpc-761	41	26	symptom	symptom	NOUN
dpc-761	41	27	of	of	ADP
dpc-761	41	28	hfs	hfs	PROPN
dpc-761	41	29	.	.	PUNCT
dpc-761	42	1	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	42	2	is	be	AUX
dpc-761	42	3	a	a	DET
dpc-761	42	4	well	well	ADV
dpc-761	42	5	-	-	PUNCT
dpc-761	42	6	known	know	VERB
dpc-761	42	7	consequence	consequence	NOUN
dpc-761	42	8	of	of	ADP
dpc-761	42	9	the	the	DET
dpc-761	42	10	antiproliferative	antiproliferative	ADJ
dpc-761	42	11	drug	drug	NOUN
dpc-761	42	12	5	5	NUM
dpc-761	42	13	-	-	PUNCT
dpc-761	42	14	fluorouracil	fluorouracil	NOUN
dpc-761	42	15	(	(	PUNCT
dpc-761	42	16	a	a	DET
dpc-761	42	17	capecitabine	capecitabine	NOUN
dpc-761	42	18	precursor	precursor	NOUN
dpc-761	42	19	)	)	PUNCT
dpc-761	42	20	,	,	PUNCT
dpc-761	42	21	generally	generally	ADV
dpc-761	42	22	occurring	occur	VERB
dpc-761	42	23	when	when	SCONJ
dpc-761	42	24	therapy	therapy	NOUN
dpc-761	42	25	is	be	AUX
dpc-761	42	26	administered	administer	VERB
dpc-761	42	27	intravenously	intravenously	ADV
dpc-761	42	28	.	.	PUNCT
dpc-761	43	1	in	in	ADP
dpc-761	43	2	such	such	ADJ
dpc-761	43	3	cases	case	NOUN
dpc-761	43	4	,	,	PUNCT
dpc-761	43	5	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	43	6	usually	usually	ADV
dpc-761	43	7	occurs	occur	VERB
dpc-761	43	8	on	on	ADP
dpc-761	43	9	photo	photo	NOUN
dpc-761	43	10	-	-	PUNCT
dpc-761	43	11	exposed	expose	VERB
dpc-761	43	12	skin	skin	NOUN
dpc-761	43	13	(	(	PUNCT
dpc-761	43	14	photomediated	photomediate	VERB
dpc-761	43	15	pathogenetic	pathogenetic	ADJ
dpc-761	43	16	mechanism	mechanism	NOUN
dpc-761	43	17	)	)	PUNCT
dpc-761	44	1	[	[	X
dpc-761	44	2	12	12	NUM
dpc-761	44	3	]	]	PUNCT
dpc-761	44	4	.	.	PUNCT
dpc-761	45	1	however	however	ADV
dpc-761	45	2	,	,	PUNCT
dpc-761	45	3	our	our	PRON
dpc-761	45	4	patient	patient	NOUN
dpc-761	45	5	presented	present	VERB
dpc-761	45	6	lentiginous	lentiginous	ADJ
dpc-761	45	7	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	45	8	on	on	ADP
dpc-761	45	9	photoprotected	photoprotecte	VERB
dpc-761	45	10	areas	area	NOUN
dpc-761	45	11	,	,	PUNCT
dpc-761	45	12	and	and	CCONJ
dpc-761	45	13	there	there	PRON
dpc-761	45	14	was	be	VERB
dpc-761	45	15	no	no	DET
dpc-761	45	16	history	history	NOUN
dpc-761	45	17	of	of	ADP
dpc-761	45	18	sun	sun	NOUN
dpc-761	45	19	exposure	exposure	NOUN
dpc-761	45	20	since	since	SCONJ
dpc-761	45	21	the	the	DET
dpc-761	45	22	start	start	NOUN
dpc-761	45	23	of	of	ADP
dpc-761	45	24	the	the	DET
dpc-761	45	25	therapy	therapy	NOUN
dpc-761	45	26	.	.	PUNCT
dpc-761	46	1	palms	palm	NOUN
dpc-761	46	2	and	and	CCONJ
dpc-761	46	3	soles	sol	NOUN
dpc-761	46	4	are	be	AUX
dpc-761	46	5	considered	consider	VERB
dpc-761	46	6	more	more	ADV
dpc-761	46	7	sensitive	sensitive	ADJ
dpc-761	46	8	to	to	ADP
dpc-761	46	9	cytotoxic	cytotoxic	ADJ
dpc-761	46	10	drugs	drug	NOUN
dpc-761	46	11	due	due	ADP
dpc-761	46	12	to	to	ADP
dpc-761	46	13	the	the	DET
dpc-761	46	14	high	high	ADJ
dpc-761	46	15	proliferation	proliferation	NOUN
dpc-761	46	16	rate	rate	NOUN
dpc-761	46	17	of	of	ADP
dpc-761	46	18	epidermal	epidermal	ADJ
dpc-761	46	19	basal	basal	ADJ
dpc-761	46	20	cells	cell	NOUN
dpc-761	46	21	.	.	PUNCT
dpc-761	47	1	in	in	ADP
dpc-761	47	2	addition	addition	NOUN
dpc-761	47	3	,	,	PUNCT
dpc-761	47	4	there	there	PRON
dpc-761	47	5	is	be	VERB
dpc-761	47	6	evidence	evidence	NOUN
dpc-761	47	7	that	that	SCONJ
dpc-761	47	8	capecitabinemetabolizing	capecitabinemetabolizing	NOUN
dpc-761	47	9	enzymes	enzyme	NOUN
dpc-761	47	10	(	(	PUNCT
dpc-761	47	11	i.e.	i.e.	X
dpc-761	47	12	,	,	PUNCT
dpc-761	47	13	tp	tp	NOUN
dpc-761	47	14	and	and	CCONJ
dpc-761	47	15	dihydropyrimidine	dihydropyrimidine	NOUN
dpc-761	47	16	dehydrogenase	dehydrogenase	NOUN
dpc-761	47	17	)	)	PUNCT
dpc-761	47	18	are	be	AUX
dpc-761	47	19	not	not	PART
dpc-761	47	20	only	only	ADV
dpc-761	47	21	expressed	express	VERB
dpc-761	47	22	in	in	ADP
dpc-761	47	23	tumour	tumour	NOUN
dpc-761	47	24	tissue	tissue	NOUN
dpc-761	47	25	but	but	CCONJ
dpc-761	47	26	also	also	ADV
dpc-761	47	27	in	in	ADP
dpc-761	47	28	palmar	palmar	NOUN
dpc-761	47	29	and	and	CCONJ
dpc-761	47	30	plantar	plantar	NOUN
dpc-761	47	31	skin	skin	NOUN
dpc-761	47	32	[	[	X
dpc-761	47	33	3,4	3,4	NUM
dpc-761	47	34	]	]	PUNCT
dpc-761	47	35	.	.	PUNCT
dpc-761	48	1	this	this	PRON
dpc-761	48	2	suggests	suggest	VERB
dpc-761	48	3	that	that	SCONJ
dpc-761	48	4	drug	drug	NOUN
dpc-761	48	5	metabolism	metabolism	NOUN
dpc-761	48	6	was	be	AUX
dpc-761	48	7	involved	involve	VERB
dpc-761	48	8	in	in	ADP
dpc-761	48	9	our	our	PRON
dpc-761	48	10	case	case	NOUN
dpc-761	48	11	more	more	ADJ
dpc-761	48	12	than	than	ADP
dpc-761	48	13	racial	racial	ADJ
dpc-761	48	14	predisposition	predisposition	NOUN
dpc-761	48	15	or	or	CCONJ
dpc-761	48	16	photo	photo	NOUN
dpc-761	48	17	-	-	PUNCT
dpc-761	48	18	sensitization	sensitization	NOUN
dpc-761	48	19	.	.	PUNCT
dpc-761	49	1	however	however	ADV
dpc-761	49	2	,	,	PUNCT
dpc-761	49	3	further	further	ADJ
dpc-761	49	4	studies	study	NOUN
dpc-761	49	5	are	be	AUX
dpc-761	49	6	needed	need	VERB
dpc-761	49	7	to	to	PART
dpc-761	49	8	assess	assess	VERB
dpc-761	49	9	the	the	DET
dpc-761	49	10	exact	exact	ADJ
dpc-761	49	11	pathogenesis	pathogenesis	NOUN
dpc-761	49	12	of	of	ADP
dpc-761	49	13	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	49	14	induced	induce	VERB
dpc-761	49	15	by	by	ADP
dpc-761	49	16	antiproliferative	antiproliferative	ADJ
dpc-761	49	17	drugs	drug	NOUN
dpc-761	49	18	manifesting	manifest	VERB
dpc-761	49	19	in	in	ADP
dpc-761	49	20	photoprotected	photoprotecte	VERB
dpc-761	49	21	areas	area	NOUN
dpc-761	49	22	in	in	ADP
dpc-761	49	23	patients	patient	NOUN
dpc-761	49	24	with	with	ADP
dpc-761	49	25	phototypes	phototype	NOUN
dpc-761	49	26	i	i	PROPN
dpc-761	49	27	-	-	PUNCT
dpc-761	49	28	ii	ii	PROPN
dpc-761	49	29	.	.	PUNCT
dpc-761	50	1	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	50	2	was	be	AUX
dpc-761	50	3	noticed	notice	VERB
dpc-761	50	4	after	after	ADP
dpc-761	50	5	two	two	NUM
dpc-761	50	6	cycles	cycle	NOUN
dpc-761	50	7	of	of	ADP
dpc-761	50	8	therapy	therapy	NOUN
dpc-761	50	9	(	(	PUNCT
dpc-761	50	10	cycles	cycle	NOUN
dpc-761	50	11	consisted	consist	VERB
dpc-761	50	12	of	of	ADP
dpc-761	50	13	1250	1250	NUM
dpc-761	50	14	mg	mg	PROPN
dpc-761	50	15	/	/	SYM
dpc-761	50	16	m²	m²	PROPN
dpc-761	50	17	twice	twice	ADV
dpc-761	50	18	daily	daily	ADV
dpc-761	50	19	for	for	ADP
dpc-761	50	20	two	two	NUM
dpc-761	50	21	weeks	week	NOUN
dpc-761	50	22	,	,	PUNCT
dpc-761	50	23	separated	separate	VERB
dpc-761	50	24	by	by	ADP
dpc-761	50	25	a	a	DET
dpc-761	50	26	7	7	NUM
dpc-761	50	27	-	-	PUNCT
dpc-761	50	28	day	day	NOUN
dpc-761	50	29	interval	interval	NOUN
dpc-761	50	30	)	)	PUNCT
dpc-761	50	31	.	.	PUNCT
dpc-761	51	1	assuming	assume	VERB
dpc-761	51	2	that	that	DET
dpc-761	51	3	capecitabine	capecitabine	NOUN
dpc-761	51	4	was	be	AUX
dpc-761	51	5	responsible	responsible	ADJ
dpc-761	51	6	for	for	ADP
dpc-761	51	7	the	the	DET
dpc-761	51	8	lesions	lesion	NOUN
dpc-761	51	9	,	,	PUNCT
dpc-761	51	10	we	we	PRON
dpc-761	51	11	enquired	enquire	VERB
dpc-761	51	12	whether	whether	SCONJ
dpc-761	51	13	the	the	DET
dpc-761	51	14	patient	patient	NOUN
dpc-761	51	15	had	have	AUX
dpc-761	51	16	ever	ever	ADV
dpc-761	51	17	previously	previously	ADV
dpc-761	51	18	had	have	VERB
dpc-761	51	19	signs	sign	NOUN
dpc-761	51	20	or	or	CCONJ
dpc-761	51	21	symptoms	symptom	NOUN
dpc-761	51	22	of	of	ADP
dpc-761	51	23	hfs	hfs	PROPN
dpc-761	51	24	.	.	PUNCT
dpc-761	52	1	the	the	DET
dpc-761	52	2	patient	patient	NOUN
dpc-761	52	3	replied	reply	VERB
dpc-761	52	4	that	that	SCONJ
dpc-761	52	5	she	she	PRON
dpc-761	52	6	had	have	AUX
dpc-761	52	7	never	never	ADV
dpc-761	52	8	previously	previously	ADV
dpc-761	52	9	experienced	experience	VERB
dpc-761	52	10	paresthesia	paresthesia	NOUN
dpc-761	52	11	,	,	PUNCT
dpc-761	52	12	burning	burn	VERB
dpc-761	52	13	pain	pain	NOUN
dpc-761	52	14	,	,	PUNCT
dpc-761	52	15	erythema	erythema	ADV
dpc-761	52	16	,	,	PUNCT
dpc-761	52	17	swelling	swelling	NOUN
dpc-761	52	18	,	,	PUNCT
dpc-761	52	19	blistering	blister	VERB
dpc-761	52	20	,	,	PUNCT
dpc-761	52	21	desquamation	desquamation	NOUN
dpc-761	52	22	or	or	CCONJ
dpc-761	52	23	ulceration	ulceration	NOUN
dpc-761	52	24	of	of	ADP
dpc-761	52	25	the	the	DET
dpc-761	52	26	feet	foot	NOUN
dpc-761	52	27	.	.	PUNCT
dpc-761	53	1	figure	figure	NOUN
dpc-761	53	2	1	1	NUM
dpc-761	53	3	.	.	PUNCT
dpc-761	54	1	diffuse	diffuse	VERB
dpc-761	54	2	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	54	3	of	of	ADP
dpc-761	54	4	the	the	DET
dpc-761	54	5	feet	foot	NOUN
dpc-761	54	6	localized	localize	VERB
dpc-761	54	7	on	on	ADP
dpc-761	54	8	the	the	DET
dpc-761	54	9	soles	sol	NOUN
dpc-761	54	10	at	at	ADP
dpc-761	54	11	presentation	presentation	NOUN
dpc-761	54	12	time	time	NOUN
dpc-761	54	13	.	.	PUNCT
dpc-761	55	1	[	[	X
dpc-761	55	2	copyright	copyright	NOUN
dpc-761	55	3	:	:	PUNCT
dpc-761	55	4	©	©	PROPN
dpc-761	55	5	2015	2015	NUM
dpc-761	55	6	tognetti	tognetti	NOUN
dpc-761	55	7	et	et	PROPN
dpc-761	55	8	al	al	PROPN
dpc-761	55	9	.	.	PROPN
dpc-761	55	10	]	]	PUNCT
dpc-761	55	11	figure	figure	NOUN
dpc-761	55	12	2	2	NUM
dpc-761	55	13	.	.	PUNCT
dpc-761	56	1	(	(	PUNCT
dpc-761	56	2	a	a	PRON
dpc-761	56	3	,	,	PUNCT
dpc-761	56	4	b	b	NOUN
dpc-761	56	5	)	)	PUNCT
dpc-761	56	6	dermoscopic	dermoscopic	NOUN
dpc-761	56	7	observation	observation	NOUN
dpc-761	56	8	showing	show	VERB
dpc-761	56	9	mottled	mottled	ADJ
dpc-761	56	10	pigmentation	pigmentation	NOUN
dpc-761	56	11	areas	area	NOUN
dpc-761	56	12	with	with	ADP
dpc-761	56	13	parallel	parallel	ADJ
dpc-761	56	14	ridge	ridge	NOUN
dpc-761	56	15	pattern	pattern	NOUN
dpc-761	56	16	.	.	PUNCT
dpc-761	57	1	(	(	PUNCT
dpc-761	57	2	b	b	X
dpc-761	57	3	)	)	PUNCT
dpc-761	57	4	pigmentation	pigmentation	NOUN
dpc-761	57	5	spares	spare	VERB
dpc-761	57	6	the	the	DET
dpc-761	57	7	acrosyringia	acrosyringia	NOUN
dpc-761	57	8	aperture	aperture	NOUN
dpc-761	57	9	of	of	ADP
dpc-761	57	10	the	the	DET
dpc-761	57	11	eccrine	eccrine	ADJ
dpc-761	57	12	glands	gland	NOUN
dpc-761	57	13	.	.	PUNCT
dpc-761	58	1	[	[	X
dpc-761	58	2	copyright	copyright	NOUN
dpc-761	58	3	:	:	PUNCT
dpc-761	58	4	©	©	PROPN
dpc-761	58	5	2015	2015	NUM
dpc-761	58	6	tognetti	tognetti	NOUN
dpc-761	58	7	et	et	PROPN
dpc-761	58	8	al	al	PROPN
dpc-761	58	9	.	.	PUNCT
dpc-761	59	1	a	a	DET
dpc-761	59	2	b	b	NOUN
dpc-761	59	3	observation	observation	NOUN
dpc-761	59	4	|	|	ADV
dpc-761	59	5	dermatol	dermatol	NOUN
dpc-761	59	6	pract	pract	PROPN
dpc-761	59	7	concept	concept	NOUN
dpc-761	59	8	2015;5(2):14	2015;5(2):14	NUM
dpc-761	59	9	81	81	NUM
dpc-761	59	10	6	6	NUM
dpc-761	59	11	.	.	PUNCT
dpc-761	60	1	narasimhan	narasimhan	PROPN
dpc-761	60	2	p	p	X
dpc-761	60	3	,	,	PUNCT
dpc-761	60	4	narasimhan	narasimhan	PROPN
dpc-761	60	5	s	s	PROPN
dpc-761	60	6	,	,	PUNCT
dpc-761	60	7	hitti	hitti	VERB
dpc-761	60	8	if	if	SCONJ
dpc-761	60	9	,	,	PUNCT
dpc-761	60	10	rachita	rachita	PROPN
dpc-761	60	11	m.	m.	PROPN
dpc-761	60	12	serious	serious	ADJ
dpc-761	60	13	handand	handand	NOUN
dpc-761	60	14	-	-	PUNCT
dpc-761	60	15	foot	foot	NOUN
dpc-761	60	16	syndrome	syndrome	NOUN
dpc-761	60	17	in	in	ADP
dpc-761	60	18	black	black	ADJ
dpc-761	60	19	patients	patient	NOUN
dpc-761	60	20	treated	treat	VERB
dpc-761	60	21	with	with	ADP
dpc-761	60	22	capecitabine	capecitabine	NOUN
dpc-761	60	23	:	:	PUNCT
dpc-761	60	24	report	report	NOUN
dpc-761	60	25	of	of	ADP
dpc-761	60	26	3	3	NUM
dpc-761	60	27	cases	case	NOUN
dpc-761	60	28	and	and	CCONJ
dpc-761	60	29	review	review	NOUN
dpc-761	60	30	of	of	ADP
dpc-761	60	31	the	the	DET
dpc-761	60	32	literature	literature	NOUN
dpc-761	60	33	.	.	PUNCT
dpc-761	61	1	cutis	cutis	PROPN
dpc-761	61	2	2004;73(2):101	2004;73(2):101	PROPN
dpc-761	61	3	-	-	PUNCT
dpc-761	61	4	6	6	NUM
dpc-761	61	5	.	.	NOUN
dpc-761	61	6	7	7	NUM
dpc-761	61	7	.	.	X
dpc-761	62	1	vázquez	vázquez	PROPN
dpc-761	62	2	-	-	PUNCT
dpc-761	62	3	bayo	bayo	PROPN
dpc-761	62	4	c	c	PROPN
dpc-761	62	5	,	,	PUNCT
dpc-761	62	6	rodríguez	rodríguez	NOUN
dpc-761	62	7	-	-	PUNCT
dpc-761	62	8	bujaldón	bujaldón	NOUN
dpc-761	62	9	al	al	PROPN
dpc-761	62	10	,	,	PUNCT
dpc-761	62	11	jiménez	jiménez	PROPN
dpc-761	62	12	-	-	PUNCT
dpc-761	62	13	puya	puya	PROPN
dpc-761	62	14	r	r	PROPN
dpc-761	62	15	,	,	PUNCT
dpc-761	62	16	et	et	PROPN
dpc-761	62	17	al	al	PROPN
dpc-761	62	18	.	.	PROPN
dpc-761	63	1	hiperpigmentación	hiperpigmentación	PROPN
dpc-761	63	2	secundaria	secundaria	PROPN
dpc-761	63	3	a	a	DET
dpc-761	63	4	capecitabina	capecitabina	PROPN
dpc-761	63	5	.	.	PUNCT
dpc-761	64	1	actas	actas	PROPN
dpc-761	64	2	dermosifiliogr	dermosifiliogr	NOUN
dpc-761	64	3	2007;98(7):491	2007;98(7):491	NOUN
dpc-761	64	4	-	-	SYM
dpc-761	64	5	3	3	NUM
dpc-761	64	6	.	.	NOUN
dpc-761	64	7	8	8	NUM
dpc-761	64	8	.	.	PUNCT
dpc-761	65	1	vickers	vickers	PROPN
dpc-761	65	2	mm	mm	PROPN
dpc-761	65	3	,	,	PUNCT
dpc-761	65	4	easaw	easaw	PROPN
dpc-761	65	5	jc	jc	PROPN
dpc-761	65	6	.	.	PROPN
dpc-761	65	7	palmar	palmar	PROPN
dpc-761	65	8	-	-	PUNCT
dpc-761	65	9	plantar	plantar	NOUN
dpc-761	65	10	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	65	11	with	with	ADP
dpc-761	65	12	capecitabine	capecitabine	NOUN
dpc-761	65	13	in	in	ADP
dpc-761	65	14	adjuvant	adjuvant	ADJ
dpc-761	65	15	colon	colon	NOUN
dpc-761	65	16	cancer	cancer	NOUN
dpc-761	65	17	.	.	PUNCT
dpc-761	66	1	j	j	PROPN
dpc-761	66	2	gastrointest	gastroint	ADJ
dpc-761	66	3	cancer	cancer	NOUN
dpc-761	66	4	2008;39(1	2008;39(1	PROPN
dpc-761	66	5	-	-	PUNCT
dpc-761	66	6	4):141	4):141	NUM
dpc-761	66	7	-	-	PUNCT
dpc-761	66	8	3	3	NUM
dpc-761	66	9	.	.	NOUN
dpc-761	66	10	9	9	NUM
dpc-761	66	11	.	.	X
dpc-761	67	1	vasudevan	vasudevan	PROPN
dpc-761	67	2	b.	b.	PROPN
dpc-761	68	1	an	an	DET
dpc-761	68	2	unusual	unusual	ADJ
dpc-761	68	3	case	case	NOUN
dpc-761	68	4	of	of	ADP
dpc-761	68	5	capecitabine	capecitabine	NOUN
dpc-761	68	6	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	68	7	:	:	PUNCT
dpc-761	68	8	is	be	AUX
dpc-761	68	9	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	68	10	a	a	DET
dpc-761	68	11	part	part	NOUN
dpc-761	68	12	of	of	ADP
dpc-761	68	13	hand	hand	NOUN
dpc-761	68	14	-	-	PUNCT
dpc-761	68	15	foot	foot	NOUN
dpc-761	68	16	syndrome	syndrome	NOUN
dpc-761	68	17	or	or	CCONJ
dpc-761	68	18	a	a	DET
dpc-761	68	19	separate	separate	ADJ
dpc-761	68	20	entity	entity	NOUN
dpc-761	68	21	?	?	PUNCT
dpc-761	69	1	indian	indian	PROPN
dpc-761	69	2	j	j	PROPN
dpc-761	69	3	pharmacol	pharmacol	PROPN
dpc-761	69	4	2010;42(5):326	2010;42(5):326	PROPN
dpc-761	69	5	-	-	PUNCT
dpc-761	69	6	28	28	NUM
dpc-761	69	7	.	.	PUNCT
dpc-761	69	8	10	10	NUM
dpc-761	69	9	.	.	PUNCT
dpc-761	70	1	van	van	PROPN
dpc-761	70	2	tienhoven	tienhoven	VERB
dpc-761	70	3	g	g	PROPN
dpc-761	70	4	,	,	PUNCT
dpc-761	70	5	wilmink	wilmink	PROPN
dpc-761	70	6	jw	jw	PROPN
dpc-761	70	7	.	.	PROPN
dpc-761	71	1	a	a	DET
dpc-761	71	2	woman	woman	NOUN
dpc-761	71	3	with	with	ADP
dpc-761	71	4	palmar	palmar	NOUN
dpc-761	71	5	and	and	CCONJ
dpc-761	71	6	plantar	plantar	ADJ
dpc-761	71	7	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	71	8	.	.	PUNCT
dpc-761	72	1	ned	ned	ADJ
dpc-761	72	2	tijdschr	tijdschr	ADJ
dpc-761	72	3	geneeskd	geneeskd	PROPN
dpc-761	72	4	2011;155(45):a4100	2011;155(45):a4100	NOUN
dpc-761	72	5	.	.	PUNCT
dpc-761	73	1	11	11	NUM
dpc-761	73	2	.	.	PUNCT
dpc-761	73	3	agharbi	agharbi	PROPN
dpc-761	73	4	fz	fz	PROPN
dpc-761	73	5	,	,	PUNCT
dpc-761	73	6	meziane	meziane	NOUN
dpc-761	73	7	m	m	PROPN
dpc-761	73	8	,	,	PUNCT
dpc-761	73	9	benhemmne	benhemmne	PROPN
dpc-761	73	10	h.	h.	PROPN
dpc-761	73	11	capecitabine	capecitabine	PROPN
dpc-761	73	12	-	-	PUNCT
dpc-761	73	13	induced	induce	VERB
dpc-761	73	14	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	73	15	followed	follow	VERB
dpc-761	73	16	by	by	ADP
dpc-761	73	17	hand	hand	NOUN
dpc-761	73	18	-	-	PUNCT
dpc-761	73	19	foot	foot	NOUN
dpc-761	73	20	syndrome	syndrome	NOUN
dpc-761	73	21	:	:	PUNCT
dpc-761	73	22	a	a	DET
dpc-761	73	23	new	new	ADJ
dpc-761	73	24	case	case	NOUN
dpc-761	73	25	report	report	NOUN
dpc-761	73	26	.	.	PUNCT
dpc-761	74	1	ann	ann	PROPN
dpc-761	74	2	dermatol	dermatol	PROPN
dpc-761	74	3	venereol	venereol	PROPN
dpc-761	74	4	2012;139(3):221	2012;139(3):221	PROPN
dpc-761	74	5	-	-	SYM
dpc-761	74	6	22	22	NUM
dpc-761	74	7	.	.	PUNCT
dpc-761	74	8	12	12	NUM
dpc-761	74	9	.	.	PUNCT
dpc-761	75	1	geddes	geddes	PROPN
dpc-761	75	2	er	er	INTJ
dpc-761	75	3	,	,	PUNCT
dpc-761	75	4	cohen	cohen	PROPN
dpc-761	75	5	pr	pr	PROPN
dpc-761	75	6	.	.	PUNCT
dpc-761	76	1	antineoplastic	antineoplastic	ADJ
dpc-761	76	2	agent	agent	NOUN
dpc-761	76	3	-	-	PUNCT
dpc-761	76	4	associated	associate	VERB
dpc-761	76	5	serpentine	serpentine	ADJ
dpc-761	76	6	supravenous	supravenous	ADJ
dpc-761	76	7	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	76	8	:	:	PUNCT
dpc-761	76	9	superficial	superficial	ADJ
dpc-761	76	10	venous	venous	ADJ
dpc-761	76	11	system	system	NOUN
dpc-761	76	12	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	76	13	following	follow	VERB
dpc-761	76	14	intravenous	intravenous	ADJ
dpc-761	76	15	chemotherapy	chemotherapy	NOUN
dpc-761	76	16	.	.	PUNCT
dpc-761	77	1	south	south	PROPN
dpc-761	77	2	med	med	PROPN
dpc-761	77	3	j	j	PROPN
dpc-761	77	4	2010;103(3):231	2010;103(3):231	PROPN
dpc-761	77	5	-	-	PROPN
dpc-761	77	6	35	35	NUM
dpc-761	77	7	.	.	NOUN
dpc-761	77	8	13	13	NUM
dpc-761	77	9	.	.	PUNCT
dpc-761	78	1	scalfoni	scalfoni	ADJ
dpc-761	78	2	fracaroli	fracaroli	PROPN
dpc-761	78	3	t	t	PROPN
dpc-761	78	4	,	,	PUNCT
dpc-761	78	5	pineiro	pineiro	PROPN
dpc-761	78	6	maceira	maceira	PROPN
dpc-761	78	7	j	j	PROPN
dpc-761	78	8	,	,	PUNCT
dpc-761	78	9	guedes	guede	VERB
dpc-761	78	10	lavorato	lavorato	NOUN
dpc-761	78	11	f	f	X
dpc-761	78	12	,	,	PUNCT
dpc-761	78	13	barcaui	barcaui	PROPN
dpc-761	78	14	c.	c.	PROPN
dpc-761	78	15	parallel	parallel	PROPN
dpc-761	78	16	ridge	ridge	PROPN
dpc-761	78	17	pattern	pattern	NOUN
dpc-761	78	18	on	on	ADP
dpc-761	78	19	dermoscopy	dermoscopy	NOUN
dpc-761	78	20	:	:	PUNCT
dpc-761	78	21	observation	observation	NOUN
dpc-761	78	22	in	in	ADP
dpc-761	78	23	non	non	ADJ
dpc-761	78	24	-	-	ADJ
dpc-761	78	25	melanoma	melanoma	ADJ
dpc-761	78	26	cases	case	NOUN
dpc-761	78	27	.	.	PUNCT
dpc-761	79	1	an	an	DET
dpc-761	79	2	bras	bras	NOUN
dpc-761	79	3	dermatol	dermatol	NOUN
dpc-761	79	4	2013;88(4):646	2013;88(4):646	NUM
dpc-761	79	5	-	-	SYM
dpc-761	79	6	8	8	NUM
dpc-761	79	7	.	.	PUNCT
dpc-761	79	8	14	14	NUM
dpc-761	79	9	.	.	PUNCT
dpc-761	80	1	minagawa	minagawa	PROPN
dpc-761	80	2	a	a	PROPN
dpc-761	80	3	,	,	PUNCT
dpc-761	80	4	koga	koga	PROPN
dpc-761	80	5	h	h	PROPN
dpc-761	80	6	,	,	PUNCT
dpc-761	80	7	saida	saida	PROPN
dpc-761	80	8	t.	t.	PROPN
dpc-761	80	9	dermoscopic	dermoscopic	PROPN
dpc-761	80	10	characteristics	characteristic	NOUN
dpc-761	80	11	of	of	ADP
dpc-761	80	12	congenital	congenital	ADJ
dpc-761	80	13	melanocytic	melanocytic	ADJ
dpc-761	80	14	nevi	nevi	NOUN
dpc-761	80	15	affecting	affect	VERB
dpc-761	80	16	acral	acral	ADJ
dpc-761	80	17	volar	volar	ADJ
dpc-761	80	18	skin	skin	NOUN
dpc-761	80	19	.	.	PUNCT
dpc-761	81	1	arch	arch	ADJ
dpc-761	81	2	dermatol	dermatol	NOUN
dpc-761	81	3	2011;147(7):809	2011;147(7):809	NUM
dpc-761	81	4	-	-	SYM
dpc-761	81	5	13	13	NUM
dpc-761	81	6	.	.	NOUN
dpc-761	81	7	15	15	NUM
dpc-761	81	8	.	.	PUNCT
dpc-761	82	1	tanioka	tanioka	NOUN
dpc-761	82	2	m.	m.	NOUN
dpc-761	82	3	benign	benign	ADJ
dpc-761	82	4	acral	acral	ADJ
dpc-761	82	5	lesion	lesion	NOUN
dpc-761	82	6	showing	show	VERB
dpc-761	82	7	parallel	parallel	ADJ
dpc-761	82	8	ridge	ridge	NOUN
dpc-761	82	9	pattern	pattern	NOUN
dpc-761	82	10	on	on	ADP
dpc-761	82	11	dermoscopy	dermoscopy	NOUN
dpc-761	82	12	.	.	PUNCT
dpc-761	83	1	j	j	PROPN
dpc-761	83	2	dermatol	dermatol	NOUN
dpc-761	83	3	2011;38(1):41	2011;38(1):41	NUM
dpc-761	83	4	-	-	SYM
dpc-761	83	5	4	4	NUM
dpc-761	83	6	.	.	NOUN
dpc-761	83	7	16	16	NUM
dpc-761	83	8	.	.	PUNCT
dpc-761	84	1	phan	phan	PROPN
dpc-761	84	2	a	a	PROPN
dpc-761	84	3	,	,	PUNCT
dpc-761	84	4	dalle	dalle	PROPN
dpc-761	84	5	s	s	PROPN
dpc-761	84	6	,	,	PUNCT
dpc-761	84	7	marcilly	marcilly	ADV
dpc-761	84	8	mc	mc	PROPN
dpc-761	84	9	,	,	PUNCT
dpc-761	84	10	bergues	bergues	PROPN
dpc-761	84	11	jp	jp	PROPN
dpc-761	84	12	,	,	PUNCT
dpc-761	84	13	thomas	thomas	PROPN
dpc-761	84	14	l.	l.	PROPN
dpc-761	84	15	benign	benign	PROPN
dpc-761	84	16	dermoscopic	dermoscopic	PROPN
dpc-761	84	17	parallel	parallel	PROPN
dpc-761	84	18	ridge	ridge	NOUN
dpc-761	84	19	pattern	pattern	NOUN
dpc-761	84	20	variants	variant	NOUN
dpc-761	84	21	.	.	PUNCT
dpc-761	85	1	arch	arch	ADJ
dpc-761	85	2	dermatol	dermatol	NOUN
dpc-761	85	3	2011;147(5):634	2011;147(5):634	PROPN
dpc-761	85	4	.	.	PROPN
dpc-761	85	5	17	17	NUM
dpc-761	85	6	.	.	PUNCT
dpc-761	85	7	kilinc	kilinc	PROPN
dpc-761	85	8	karaarslan	karaarslan	PROPN
dpc-761	85	9	i	i	PROPN
dpc-761	85	10	,	,	PUNCT
dpc-761	85	11	akalin	akalin	PROPN
dpc-761	85	12	t	t	PROPN
dpc-761	85	13	,	,	PUNCT
dpc-761	85	14	unal	unal	PROPN
dpc-761	85	15	i	i	PROPN
dpc-761	85	16	,	,	PUNCT
dpc-761	85	17	ozdemir	ozdemir	PROPN
dpc-761	85	18	f.	f.	PROPN
dpc-761	85	19	atypical	atypical	ADJ
dpc-761	85	20	melanosis	melanosis	NOUN
dpc-761	85	21	of	of	ADP
dpc-761	85	22	the	the	DET
dpc-761	85	23	foot	foot	NOUN
dpc-761	85	24	showing	show	VERB
dpc-761	85	25	a	a	DET
dpc-761	85	26	dermoscopic	dermoscopic	ADJ
dpc-761	85	27	feature	feature	NOUN
dpc-761	85	28	of	of	ADP
dpc-761	85	29	the	the	DET
dpc-761	85	30	parallel	parallel	PROPN
dpc-761	85	31	ridge	ridge	NOUN
dpc-761	85	32	pattern	pattern	NOUN
dpc-761	85	33	.	.	PUNCT
dpc-761	86	1	j	j	PROPN
dpc-761	86	2	dermatol	dermatol	NOUN
dpc-761	86	3	2007;34(1):56	2007;34(1):56	NUM
dpc-761	86	4	-	-	SYM
dpc-761	86	5	9	9	NUM
dpc-761	86	6	.	.	PUNCT
dpc-761	86	7	dermoscopic	dermoscopic	PROPN
dpc-761	86	8	findings	finding	NOUN
dpc-761	86	9	from	from	ADP
dpc-761	86	10	acral	acral	ADJ
dpc-761	86	11	pigmented	pigmented	ADJ
dpc-761	86	12	lesions	lesion	NOUN
dpc-761	86	13	are	be	AUX
dpc-761	86	14	sometimes	sometimes	ADV
dpc-761	86	15	confusing	confusing	ADJ
dpc-761	86	16	.	.	PUNCT
dpc-761	87	1	in	in	ADP
dpc-761	87	2	recent	recent	ADJ
dpc-761	87	3	years	year	NOUN
dpc-761	87	4	,	,	PUNCT
dpc-761	87	5	various	various	ADJ
dpc-761	87	6	authors	author	NOUN
dpc-761	87	7	have	have	AUX
dpc-761	87	8	highlighted	highlight	VERB
dpc-761	87	9	parallel	parallel	ADJ
dpc-761	87	10	ridge	ridge	NOUN
dpc-761	87	11	pattern	pattern	NOUN
dpc-761	87	12	not	not	PART
dpc-761	87	13	only	only	ADV
dpc-761	87	14	in	in	ADP
dpc-761	87	15	acral	acral	ADJ
dpc-761	87	16	melanoma	melanoma	NOUN
dpc-761	87	17	but	but	CCONJ
dpc-761	87	18	also	also	ADV
dpc-761	87	19	in	in	ADP
dpc-761	87	20	certain	certain	ADJ
dpc-761	87	21	benign	benign	ADJ
dpc-761	87	22	plantar	plantar	NOUN
dpc-761	87	23	lesions	lesion	NOUN
dpc-761	87	24	,	,	PUNCT
dpc-761	87	25	such	such	ADJ
dpc-761	87	26	as	as	ADP
dpc-761	87	27	congenital	congenital	ADJ
dpc-761	87	28	or	or	CCONJ
dpc-761	87	29	acquired	acquire	VERB
dpc-761	87	30	acral	acral	ADJ
dpc-761	87	31	nevi	nevi	PROPN
dpc-761	87	32	,	,	PUNCT
dpc-761	87	33	subcorneal	subcorneal	ADJ
dpc-761	87	34	hemorrhage	hemorrhage	NOUN
dpc-761	87	35	,	,	PUNCT
dpc-761	87	36	dye	dye	NOUN
dpc-761	87	37	-	-	PUNCT
dpc-761	87	38	related	relate	VERB
dpc-761	87	39	pigmentation	pigmentation	NOUN
dpc-761	87	40	and	and	CCONJ
dpc-761	87	41	drug	drug	NOUN
dpc-761	87	42	-	-	PUNCT
dpc-761	87	43	induced	induce	VERB
dpc-761	87	44	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	87	45	,	,	PUNCT
dpc-761	87	46	especially	especially	ADV
dpc-761	87	47	in	in	ADP
dpc-761	87	48	patients	patient	NOUN
dpc-761	87	49	with	with	ADP
dpc-761	87	50	phototypes	phototype	NOUN
dpc-761	87	51	iii	iii	NOUN
dpc-761	87	52	-	-	PUNCT
dpc-761	87	53	vi	vi	NOUN
dpc-761	88	1	[	[	X
dpc-761	88	2	13	13	NUM
dpc-761	88	3	-	-	SYM
dpc-761	88	4	17	17	NUM
dpc-761	88	5	]	]	PUNCT
dpc-761	88	6	.	.	PUNCT
dpc-761	89	1	in	in	ADP
dpc-761	89	2	particular	particular	ADJ
dpc-761	89	3	,	,	PUNCT
dpc-761	89	4	fracaroli	fracaroli	PROPN
dpc-761	89	5	et	et	PROPN
dpc-761	89	6	al	al	PROPN
dpc-761	89	7	emphasised	emphasise	VERB
dpc-761	89	8	the	the	DET
dpc-761	89	9	importance	importance	NOUN
dpc-761	89	10	of	of	ADP
dpc-761	89	11	obliteration	obliteration	NOUN
dpc-761	89	12	of	of	ADP
dpc-761	89	13	eccrine	eccrine	ADJ
dpc-761	89	14	gland	gland	NOUN
dpc-761	89	15	ducts	duct	NOUN
dpc-761	89	16	by	by	ADP
dpc-761	89	17	neoplastic	neoplastic	ADJ
dpc-761	89	18	proliferation	proliferation	NOUN
dpc-761	89	19	of	of	ADP
dpc-761	89	20	melanocytes	melanocyte	NOUN
dpc-761	89	21	in	in	ADP
dpc-761	89	22	distinguishing	distinguish	VERB
dpc-761	89	23	malignant	malignant	ADJ
dpc-761	89	24	and	and	CCONJ
dpc-761	89	25	benign	benign	ADJ
dpc-761	89	26	acral	acral	ADJ
dpc-761	89	27	pigmented	pigment	VERB
dpc-761	89	28	lesions	lesion	NOUN
dpc-761	89	29	with	with	ADP
dpc-761	89	30	parallel	parallel	ADJ
dpc-761	89	31	ridge	ridge	NOUN
dpc-761	89	32	pattern	pattern	NOUN
dpc-761	89	33	[	[	X
dpc-761	89	34	13	13	NUM
dpc-761	89	35	]	]	PUNCT
dpc-761	89	36	.	.	PUNCT
dpc-761	90	1	indeed	indeed	ADV
dpc-761	90	2	,	,	PUNCT
dpc-761	90	3	the	the	DET
dpc-761	90	4	coexistence	coexistence	NOUN
dpc-761	90	5	these	these	DET
dpc-761	90	6	two	two	NUM
dpc-761	90	7	dermoscopic	dermoscopic	ADJ
dpc-761	90	8	signs	sign	NOUN
dpc-761	90	9	(	(	PUNCT
dpc-761	90	10	i.e.	i.e.	X
dpc-761	90	11	,	,	PUNCT
dpc-761	90	12	parallel	parallel	ADJ
dpc-761	90	13	ridge	ridge	NOUN
dpc-761	90	14	pattern	pattern	NOUN
dpc-761	90	15	and	and	CCONJ
dpc-761	90	16	acrosyringium	acrosyringium	NOUN
dpc-761	90	17	obliteration	obliteration	NOUN
dpc-761	90	18	)	)	PUNCT
dpc-761	90	19	is	be	AUX
dpc-761	90	20	considered	consider	VERB
dpc-761	90	21	highly	highly	ADV
dpc-761	90	22	indicative	indicative	ADJ
dpc-761	90	23	of	of	ADP
dpc-761	90	24	acral	acral	ADJ
dpc-761	90	25	melanoma	melanoma	NOUN
dpc-761	90	26	.	.	PUNCT
dpc-761	91	1	however	however	ADV
dpc-761	91	2	,	,	PUNCT
dpc-761	91	3	it	it	PRON
dpc-761	91	4	should	should	AUX
dpc-761	91	5	be	be	AUX
dpc-761	91	6	borne	bear	VERB
dpc-761	91	7	in	in	ADP
dpc-761	91	8	mind	mind	NOUN
dpc-761	91	9	that	that	SCONJ
dpc-761	91	10	these	these	DET
dpc-761	91	11	two	two	NUM
dpc-761	91	12	signs	sign	NOUN
dpc-761	91	13	can	can	AUX
dpc-761	91	14	also	also	ADV
dpc-761	91	15	be	be	AUX
dpc-761	91	16	detected	detect	VERB
dpc-761	91	17	in	in	ADP
dpc-761	91	18	benign	benign	ADJ
dpc-761	91	19	lesions	lesion	NOUN
dpc-761	91	20	,	,	PUNCT
dpc-761	91	21	such	such	ADJ
dpc-761	91	22	as	as	ADP
dpc-761	91	23	plantar	plantar	NOUN
dpc-761	91	24	hemorrhage	hemorrhage	NOUN
dpc-761	91	25	(	(	PUNCT
dpc-761	91	26	e.g.	e.g.	ADV
dpc-761	91	27	,	,	PUNCT
dpc-761	91	28	“	"	PUNCT
dpc-761	91	29	black	black	ADJ
dpc-761	91	30	heel	heel	NOUN
dpc-761	91	31	”	"	PUNCT
dpc-761	91	32	)	)	PUNCT
dpc-761	91	33	,	,	PUNCT
dpc-761	91	34	dye	dye	NOUN
dpc-761	91	35	-	-	PUNCT
dpc-761	91	36	related	relate	VERB
dpc-761	91	37	pigmentation	pigmentation	NOUN
dpc-761	91	38	and	and	CCONJ
dpc-761	91	39	,	,	PUNCT
dpc-761	91	40	as	as	ADP
dpc-761	91	41	in	in	ADP
dpc-761	91	42	the	the	DET
dpc-761	91	43	present	present	ADJ
dpc-761	91	44	case	case	NOUN
dpc-761	91	45	,	,	PUNCT
dpc-761	91	46	drug	drug	NOUN
dpc-761	91	47	-	-	PUNCT
dpc-761	91	48	induced	induce	VERB
dpc-761	91	49	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	91	50	.	.	PUNCT
dpc-761	92	1	references	reference	NOUN
dpc-761	92	2	1	1	NUM
dpc-761	92	3	.	.	PUNCT
dpc-761	92	4	walko	walko	PROPN
dpc-761	92	5	cm	cm	PROPN
dpc-761	92	6	,	,	PUNCT
dpc-761	92	7	lindley	lindley	PROPN
dpc-761	92	8	c.	c.	PROPN
dpc-761	92	9	capecitabine	capecitabine	PROPN
dpc-761	92	10	:	:	PUNCT
dpc-761	92	11	a	a	DET
dpc-761	92	12	review	review	NOUN
dpc-761	92	13	.	.	PUNCT
dpc-761	92	14	 	 	SPACE
dpc-761	93	1	clin	clin	PROPN
dpc-761	93	2	ther	ther	PROPN
dpc-761	93	3	2005;27(1):23–44	2005;27(1):23–44	PROPN
dpc-761	93	4	.	.	PROPN
dpc-761	93	5	2	2	NUM
dpc-761	93	6	.	.	X
dpc-761	93	7	mikhail	mikhail	PROPN
dpc-761	93	8	se	se	PROPN
dpc-761	93	9	,	,	PUNCT
dpc-761	93	10	sun	sun	PROPN
dpc-761	93	11	jf	jf	PROPN
dpc-761	93	12	,	,	PUNCT
dpc-761	93	13	marshall	marshall	PROPN
dpc-761	93	14	jl	jl	PROPN
dpc-761	93	15	.	.	PUNCT
dpc-761	94	1	safety	safety	NOUN
dpc-761	94	2	of	of	ADP
dpc-761	94	3	capecitabine	capecitabine	NOUN
dpc-761	94	4	:	:	PUNCT
dpc-761	94	5	a	a	DET
dpc-761	94	6	review	review	NOUN
dpc-761	94	7	.	.	PUNCT
dpc-761	95	1	expert	expert	NOUN
dpc-761	95	2	opin	opin	NOUN
dpc-761	95	3	drug	drug	NOUN
dpc-761	95	4	saf	saf	PROPN
dpc-761	95	5	2010;9(5):831	2010;9(5):831	PROPN
dpc-761	95	6	-	-	SYM
dpc-761	95	7	41	41	NUM
dpc-761	95	8	.	.	PUNCT
dpc-761	96	1	3	3	X
dpc-761	96	2	.	.	X
dpc-761	96	3	saif	saif	PROPN
dpc-761	96	4	mw	mw	PROPN
dpc-761	96	5	.	.	PROPN
dpc-761	96	6	capecitabine	capecitabine	NOUN
dpc-761	96	7	and	and	CCONJ
dpc-761	96	8	hand	hand	NOUN
dpc-761	96	9	-	-	PUNCT
dpc-761	96	10	foot	foot	NOUN
dpc-761	96	11	syndrome	syndrome	NOUN
dpc-761	96	12	.	.	PUNCT
dpc-761	97	1	expert	expert	NOUN
dpc-761	97	2	opin	opin	NOUN
dpc-761	97	3	drug	drug	NOUN
dpc-761	97	4	saf	saf	PROPN
dpc-761	97	5	2011;10(2):159–69	2011;10(2):159–69	NUM
dpc-761	97	6	.	.	PROPN
dpc-761	97	7	4	4	NUM
dpc-761	97	8	.	.	X
dpc-761	98	1	milano	milano	PROPN
dpc-761	98	2	g	g	PROPN
dpc-761	98	3	,	,	PUNCT
dpc-761	98	4	 	 	SPACE
dpc-761	98	5	etienne	etienne	PROPN
dpc-761	98	6	-	-	PUNCT
dpc-761	98	7	grimaldi	grimaldi	PROPN
dpc-761	98	8	mc	mc	PROPN
dpc-761	98	9	,	,	PUNCT
dpc-761	98	10	 	 	SPACE
dpc-761	98	11	mari	mari	PROPN
dpc-761	98	12	m	m	PROPN
dpc-761	98	13	,	,	PUNCT
dpc-761	98	14	et	et	PROPN
dpc-761	98	15	al	al	PROPN
dpc-761	98	16	.	.	PUNCT
dpc-761	98	17	candidate	candidate	NOUN
dpc-761	98	18	mechanisms	mechanism	NOUN
dpc-761	98	19	for	for	ADP
dpc-761	98	20	capecitabine	capecitabine	NOUN
dpc-761	98	21	-	-	PUNCT
dpc-761	98	22	related	relate	VERB
dpc-761	98	23	hand	hand	NOUN
dpc-761	98	24	–	–	PUNCT
dpc-761	98	25	foot	foot	NOUN
dpc-761	98	26	syndrome	syndrome	NOUN
dpc-761	98	27	.	.	PUNCT
dpc-761	99	1	br	br	PROPN
dpc-761	100	1	j	j	PROPN
dpc-761	100	2	clin	clin	PROPN
dpc-761	100	3	pharmacol	pharmacol	PROPN
dpc-761	100	4	2008;66(1):88–95	2008;66(1):88–95	PROPN
dpc-761	100	5	.	.	PROPN
dpc-761	100	6	5	5	NUM
dpc-761	100	7	.	.	X
dpc-761	101	1	pui	pui	PROPN
dpc-761	101	2	jc	jc	PROPN
dpc-761	101	3	,	,	PUNCT
dpc-761	101	4	 	 	SPACE
dpc-761	101	5	meehan	meehan	PROPN
dpc-761	101	6	s	s	PROPN
dpc-761	101	7	,	,	PUNCT
dpc-761	101	8	 	 	SPACE
dpc-761	101	9	moskovits	moskovit	NOUN
dpc-761	101	10	t.	t.	PROPN
dpc-761	101	11	capecitabine	capecitabine	PROPN
dpc-761	101	12	 	 	SPACE
dpc-761	101	13	induced	induce	VERB
dpc-761	101	14	cutaneous	cutaneous	ADJ
dpc-761	101	15	 	 	SPACE
dpc-761	101	16	hyperpigmentation	hyperpigmentation	NOUN
dpc-761	101	17	:	:	PUNCT
dpc-761	101	18	report	report	NOUN
dpc-761	101	19	of	of	ADP
dpc-761	101	20	a	a	DET
dpc-761	101	21	case	case	NOUN
dpc-761	101	22	.	.	PUNCT
dpc-761	102	1	j	j	PROPN
dpc-761	102	2	drugs	drug	NOUN
dpc-761	102	3	dermatol	dermatol	VERB
dpc-761	102	4	2002;1(2):202	2002;1(2):202	NUM
dpc-761	102	5	-	-	SYM
dpc-761	102	6	5	5	NUM
dpc-761	102	7	.	.	PUNCT